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ABSTRACT
A 14 year-old patient was admitted because of a history of polyuria and polydipsia. A diagnosis
of central diabetes insipidus (CDI) accompanied by growth hormone (GH) and gonadotropin
deficiency was made. Hypophyseal magnetic resonance imaging (MRI) of the patient demons-
trated isolated pituitary stalk enlargement. Although GH deficiency and gonadotropin deficien-
cy were transient, CDI was persistent despite the regression of the pituitary stalk enlargement
over the 4 years of follow-up. 
Conflict of interest: None declared
INTRODUCTION
Central diabetes insipidus (CDI) is a
condition characterized by excretion of
abnormally large volumes of dilute urine
due to deficiency of the arginine-vaso-
pressin peptide.(1, 2, 3, 4) CDI may result
from a lesion of the hypothalamic neuro-
hypo-physeal system. Magnetic resonance
imaging (MRI) has revealed loss of bright
T1 signal of the posterior pituitary with or
without pituitary stalk thickening (PST) in
some cases of idiopathic CDI as well as
some cases of secondary CDI due to an
infiltrative process or neoplasia. The clini-
cal features of a lesion involving the hypo-
thalamus and pituitary stalk depend on its
location, its degree of extension, and rate
of its progression.(5, 6, 7, 8) Pituitary stalk
involvement may lead to isolated or mul-
tiple anterior pituitary hormone dysfunc-
tion and/or posterior pituitary dysfunc-
tion. There may be a change in PST at fol-
low up.(9)
This paper presents the case of a 14
year-old boy with transient pituitary stalk
enlargement and growth hormone (GH)
deficiency and central hypogonadism, and
with a persistent loss of MRI - bright T1
signal of posterior pituitary and CDI over a
four-year follow up period. 
CASE REPORT
A 14 year-old male patient with a histo-
ry of polyuria and polydipsia in the past 2
months was admitted to our hospital. He
was prepubertal and of short stature
(height SDS: -2.26, parentally adjusted
height SDS: -2.64). He ingested 8 L of fluid
and urinated 5-6 L daily. At initial evalua-
tion he appeared well hydrated and had
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normal vital signs. His basal urinary osmolal-
ity, serum osmolality and the ratio of urinary
osmolality to serum osmolality were, 40
mosm/kg H2O, 299 mosm/kg H2O and 0.13,
respectively. Serum sodium, potassium, cal-
cium, phosphorus levels were within normal
limits. Water deprivation test and desmo-
pressin (dDAVP) test confirmed the diagno-
sis of complete CDI. After subcutaneous
dDAVP administration, urinary osmolality
increase from the baseline was 174%. There
was no family history of CDI, no history of
head trauma/injury or evidence of systemic
diseases such as Langerhans cell hystiocyto-
sis (LCH), sarcoidosis, tuberculosis or neuro-
logical deficits. 
MRI of the pituitary region showed a
thickened pituitary stalk (5 mm) and loss of
the hyperintense signal of the posterior pitu-
itary. Transsphenoidal biopsy of the lesion
was not done. Desmopressin treatment was
initiated. Complete anterior pituitary
endocrine function evaluation included
measurement of growth hormone response
to pharmacological stimulation tests (L-Dopa
test and insulin tolerance test-ITT); baseline
and ITT stimulated cortisol levels; thyroid
function tests; basal testosterone level,
luteinizing hormone (LH) and follicle stimu-
lating hormone (FSH) response to
gonadotropin releasing hormone (GnRH)
stimulation, and prolactin level. The patient
did not have central hypothyroidism,
adrenocorticotropic hormone (ACTH) defi-
ciency or hyperprolactinemia. He suffered
from both complete growth hormone (GH)
deficiency (L-Dopa stimulated GH peak was
0.65 ng/mL, ITT stimulated GH peak was
0.38 ng/mL) and hypogonadotropic hypogo-
nadism. At 14 years of age he had bilateral
testicular volumes of less than 4 mL, basal
testosterone level was within the prepuber-
tal range (13 ng/dL) and GnRH stimulated
LH and FSH were 3.38 mIU/mL and 4.22
mIU/mL, respectively. GH stimulation tests
were performed after priming with sex
steroid. In the differential diagnosis, pituitary
tumor (such as germinoma), LCH, sarcoido-
Figure 1: MRI at admission: A 5 mm infundibular thickness,
absence of posterior hypophyseal bright spot 
Figure 2: MRI at follow-up: Enlargement of PST from 5 mm
to 7 mm 
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sis or tuberculosis were considered. High
resolution CT of the thorax and a bone sur-
vey for LCH were normal. A negative result
was obtained for human chorionic
gonadotropin (hCG) and a-fetoprotein lev-
els in the cerebrospinal fluid, which were
measured to eliminate a diagnosis of germi-
noma. The patient had no systemic evidence
of sarcoidosis, and hyperprolactinemia was
not detected. Serum angiotensin converting
enzyme was within normal levels. Chest X-
ray, intradermal tuberculin test, cere-
brospinal fluid analysis yielded negative
results for tuberculosis. 
The patient was followed clinically, backed
up with endocrine and MRI evaluation for 4
years, with no treatment other than desmo-
pressin as a hormone substitution therapy. 
His pituitary stalk size showed a change
over the four years of follow up.
Hypophyseal MRI, which was taken every 3
to 4 months, demonstrated that PST enlarged
from 5 mm to 7 mm during the first 10
months of follow-up. After that, complete
regression of pituitary stalk enlargement
occurred over the subsequent 14 months.
The time interval between the diagnosis and
the complete regression of PST enlargement
was 2 years. PST decreased from 7 mm to
2.5 mm, (Figure 1) and retained its normal
size for the last 2 years. The loss of bright
signal on MRI remained unchanged during
the follow-up period.
Despite improvement of the GH defi-
ciency and hypogonadotropic hypogo-
nadism, CDI was persistent. At the most
recent evaluation when the patient was 17.9
years of age, GH response to ITT was 20
ng/mL, testicular volume was 20 mL and
basal testosterone level was 232 ng/dL. His
height was 169.8 cm, height SDS was -0.59,
and he had a +1.67 SD height gain without
GH treatment. Because of the regression of
PST, absence of progression to any systemic
disease or pituitary tumor over 4 years, an
autoimmune hypophysitis was suspected in
this patient. 
DISCUSSION
In this article clinical, hormonal and radio-
logical features in a 14 years-old boy with
persistent CDI but with regression of PST
over the 4 years follow-up period is reported. 
Mass lesions involving the hypothalamic-
pituitary system constitute diagnostic chal-
lenges for endocrinologists, particularly
since the introduction of MRI. Isolated GH
deficiency or multiple pituitary hormone
deficiency (MPHD) develop in 90-94% of
patients with CDI and PST.(4) Our patient
presented with a combination of CDI and
transient MPHD including GH deficiency
and hypogonadotropic hypogonadism. 
Pituitary stalk and hypothalamus involve-
ment may be due to cystic, neoplastic, infec-
tious and inflammatory processes.(3, 8, 9,
10, 11, 12, 13, 14, 15, 16, 17, 18, 19) PST has
a wide differential diagnosis, but almost all
patients present with CDI.(11) In one third
of patients with CDI, the pituitary stalk is
thickened, suggesting infiltrative disease.(4)
Investigation for hypophyseal tuberculoma,
Figure 3: MRI at follow-up: Regression
of the PST from 7 mm to 2.5 mm on MRI sarcoidosis, LCH, germinoma and autoim-
mune hypophysitisis are important in the
differential diagnosis of the condition.(10) In
about 60% of patients with PST, the etiology
of the CDI remains undetermined, but in
approximately 15-20%, LCH and occult ger-
minoma each account for the CDI. In the
report by Czernichow et al(7) on 26 children
with CDI and PST, four had germinoma, five
had LCH, and 17 were diagnosed as idio-
pathic. 
PST is defined as exceeding 2.5 mm in
width.(9) The initial PST in our patient was
5 mm, and progressed to 7 mm within a 10
month period. This was followed by a spon-
taneous regression to 2.5 mm over the fol-
lowing 14 months, and retaining a normal
size in the subsequent 2 years. Excluding
the likely diseases in the differential diagno-
sis, the patient was initially designated as
idiopathic, but progressive PST in the follo-
wing 10 months of follow-up suggested an
occult germinoma. However, normal cereb-
rospinal hCG and a-fetoprotein values and
spontaneous regression of the PST over the
subsequent 2 years without recurrence by
the 4th year, excluded this diagnosis. Imura
et al(19) showed that autoimmune CDI co-
uld be due to lymphocytic infundibulo-neu-
rohypophysitis proven by infiltration of
lymphocytes and plasma-cells on biopsy
samples of the pituitary stalk or suggested
by presence of PST on MRI which disappea-
red over time spontaneously, just like in our
patient. Although antibodies to AVP secre-
ting cells have not been studied in our pa-
tient, the persistence of CDI despite impro-
vement of the GH deficiency and hypogo-
nadotropic hypogonadism suggest autoim-
mune hypophysitis.
In this patient, the pubertal delay could
be attributed to constitutional pubertal
delay. However, onset of puberty sponta-
neously following PST regression, together
with improvement of GH deficiency, led us
to think that the pubertal delay was due to
transient hypogonadotropic hypogonadism.
GH deficiency could also be attributed to
false positive results of GH tests especially in
peripubertal ages, but the tests had been
conducted after priming with sex steroids
and GH tests are still considered as the gold
standard for the diagnosis of GH deficiency.
In conclusion, long term follow up
should be made in children with unex-
plained CDI and PST. PST related endocrine
disturbances such as GH deficiency, and
hypogonadotrophic hypogonadism, with the
exception of CDI, may be transient during
long term follow-up with regression of PST.
Provided cerebrospinal fluid investigation
results are normal, biopsy of the enlarged
stalk may not be necessary, since sponta-
neous recovery may occur.
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